Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Life Science

• Publication date

  2012-07-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.lfs.2012.06.005PMID 22727796PMCID PMC3412179
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.

  2012cited by this paper
• Reciprocal changes of renal neuronal nitric oxide synthase-α and -β associated with renal progression in a neonatal 5/6 nephrectomized rat model.

  2011cited by this paper
• Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.

  2011cited by this paper
• Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase.

  2011cited by this paper
• Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats

  2011cited by this paper
• The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.

  2011cited by this paper
• Relaxin Ameliorates Hypertension and Increases Nitric Oxide Metabolite Excretion in Angiotensin II But Not N&ohgr;-Nitro-L-Arginine Methyl Ester Hypertensive Rats

  2011cited by this paper
• Nebivolol Attenuates Maladaptive Proximal Tubule Remodeling in Transgenic Rats

  2010cited by this paper
• Asymmetric dimethylarginine in angiotensin II-induced hypertension.

  2010cited by this paper
• Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure.

  2009cited by this paper
• Splice variants of neuronal nitric oxide synthase are present in the rat kidney.

  2009cited by this paper
• Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.

  2009cited by this paper
• Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.

  2009cited by this paper
• Nitric oxide deficiency in chronic kidney disease.

  2008cited by this paper
• Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.

  2008cited by this paper
• Effects of Nebivolol on Endothelial Gene Expression during Oxidative Stress in Human Umbilical Vein Endothelial Cells

  2008cited by this paper
• Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.

  2008cited by this paper
• Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation.

  2008cited by this paper
• Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits.

  2008cited by this paper
• Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.

  2007cited by this paper
• Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum.

  2007cited by this paper
• Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction

  2007cited by this paper
• Nebivolol Induces Nitric Oxide Release in the Heart Through Inducible Nitric Oxide Synthase Activation

  2007cited by this paper
• Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat.

  2007cited by this paper
• Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.

  2007cited by this paper
• Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II–Treated Rats

  2006cited by this paper
• The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery.

  2005cited by this paper
• Endothelial β3-Adrenoreceptors Mediate Nitric Oxide–Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation β-Blocker Nebivolol

  2005cited by this paper
• Experimental evidences of nitric oxide‐dependent vasodilatory activity of nebivolol, a third‐generation β‐blocker

  2004cited by this paper
• Renal neuronal nitric oxide synthase protein expression as a marker of renal injury.

  2003cited by this paper
• Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells

  2003cited by this paper
• Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase.

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• The role of renin–angiotensin– aldosterone system inhibition in chronic kidney disease

  2003cited by this paper
• Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function.

  2001cited by this paper
• The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.

  1998cited by this paper
• Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production.

  1995cited by this paper
• Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury.

  1994cited by this paper
• Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.

  1986cited by this paper
• Original Report: Laboratory Investigation Nebivolol Reduces Proteinuria and Renal Nadph Oxidase-generated Reactive Oxygen Species in the Transgenic Ren2 Rat

  year unknowncited by this paper
• Original Report: Laboratory Investigation Salt-induced Renal Injury in Spontaneously Hypertensive Rats: Effects of Nebivolol

  year unknowncited by this paper

• Kidney Programming and Hypertension: Linking Prenatal Development to Adulthood

  2024cites this paper
• The Renin–Angiotensin System and Cardiovascular–Kidney–Metabolic Syndrome: Focus on Early-Life Programming

  2024cites this paper
• Does Nebivolol have renoprotective action in patients with chronic kidney disease conditions? An integrative review.

  2021cites this paper
• Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment.

  2020cites this paper
• Modulation of eNOS/iNOS by nebivolol protects against cyclosporine A-mediated nephrotoxicity through targeting inflammatory and apoptotic pathways.

  2019cites this paper
• Embryonic kidney function in a chronic renal failure model in rodents

  2017cites this paper
• Embryonic kidney function in a chronic renal failure model in rodents

  2017cites this paper
• The role played by oxidative stress in evoking the exercise pressor reflex in health and simulated peripheral artery disease

  2017cites this paper
• Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.

  2016cites this paper
• Beta-adrenoblockers of third generation as medicines for drug therapy of patients with chronic kidney disease

  2016cites this paper
• Cardiac function and tolerance to ischemia-reperfusion injury in chronic kidney disease.

  2014cites this paper
• Cardiac function is preserved following 4 weeks of voluntary wheel running in a rodent model of chronic kidney disease.

  2014cites this paper
• Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiology

  2014cites this paper
• Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME

  2013cites this paper